Roland Faigle1, Victor C Urrutia2, Lisa A Cooper2, Rebecca F Gottesman2. 1. From the Department of Neurology (R.F., V.C.U., R.F.G.) and Department of Medicine (L.A.C.), Johns Hopkins University School of Medicine, Baltimore, MD. rfaigle1@jhmi.edu. 2. From the Department of Neurology (R.F., V.C.U., R.F.G.) and Department of Medicine (L.A.C.), Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
BACKGROUND AND PURPOSE: Intravenous thrombolysis (IVT) is underutilized in ethnic minorities and women. To disentangle individual and system-based factors determining disparities in IVT use, we investigated race/sex differences in IVT utilization among hospitals serving varying proportions of minority patients. METHODS: Ischemic stroke admissions were identified from the Nationwide Inpatient Sample between 2007 and 2011. Hospitals were categorized based on the percentage of minority patients admitted with stroke (<25% minority patients [white hospitals], 25% to 50% minority patients [mixed hospitals], or >50% minority patients [minority hospitals]). Logistic regression was used to evaluate the association between race/sex and IVT use within and between the different hospital strata. RESULTS: Among 337 201 stroke admissions, white men had the highest odds of IVT among all race/sex groups in any hospital strata, and the odds of IVT for white men did not differ by hospital strata. For white women and minority men, the odds of IVT were significantly lower in minority hospitals compared with white hospitals (odds ratio, 0.83; 95% confidence interval, 0.71-0.97, for white women; and odds ratio, 0.82; 95% confidence interval, 0.69-0.99, for minority men). Race disparities in IVT use among women were observed in white hospitals (odds ratio, 0.88; 95% confidence interval, 0.78-0.99, in minority compared with white women), but not in minority hospitals (odds ratio, 0.94, 95% confidence interval, 0.82-1.09). Sex disparities in IVT use were observed among whites but not among minorities. CONCLUSIONS: Minority men and white women have significantly lower odds of IVT in minority hospitals compared with white hospitals. IVT use in white men does not differ by hospital strata.
BACKGROUND AND PURPOSE: Intravenous thrombolysis (IVT) is underutilized in ethnic minorities and women. To disentangle individual and system-based factors determining disparities in IVT use, we investigated race/sex differences in IVT utilization among hospitals serving varying proportions of minority patients. METHODS:Ischemic stroke admissions were identified from the Nationwide Inpatient Sample between 2007 and 2011. Hospitals were categorized based on the percentage of minority patients admitted with stroke (<25% minority patients [white hospitals], 25% to 50% minority patients [mixed hospitals], or >50% minority patients [minority hospitals]). Logistic regression was used to evaluate the association between race/sex and IVT use within and between the different hospital strata. RESULTS: Among 337 201 stroke admissions, white men had the highest odds of IVT among all race/sex groups in any hospital strata, and the odds of IVT for white men did not differ by hospital strata. For white women and minority men, the odds of IVT were significantly lower in minority hospitals compared with white hospitals (odds ratio, 0.83; 95% confidence interval, 0.71-0.97, for white women; and odds ratio, 0.82; 95% confidence interval, 0.69-0.99, for minority men). Race disparities in IVT use among women were observed in white hospitals (odds ratio, 0.88; 95% confidence interval, 0.78-0.99, in minority compared with white women), but not in minority hospitals (odds ratio, 0.94, 95% confidence interval, 0.82-1.09). Sex disparities in IVT use were observed among whites but not among minorities. CONCLUSIONS: Minority men and white women have significantly lower odds of IVT in minority hospitals compared with white hospitals. IVT use in white men does not differ by hospital strata.
Authors: Ralph L Sacco; Scott E Kasner; Joseph P Broderick; Louis R Caplan; J J Buddy Connors; Antonio Culebras; Mitchell S V Elkind; Mary G George; Allen D Hamdan; Randall T Higashida; Brian L Hoh; L Scott Janis; Carlos S Kase; Dawn O Kleindorfer; Jin-Moo Lee; Michael E Moseley; Eric D Peterson; Tanya N Turan; Amy L Valderrama; Harry V Vinters Journal: Stroke Date: 2013-05-07 Impact factor: 7.914
Authors: Negar Asdaghi; Jose G Romano; Kefeng Wang; Maria A Ciliberti-Vargas; Sebastian Koch; Hannah Gardener; Chuanhui Dong; David Z Rose; Salina P Waddy; Mary Robichaux; Enid J Garcia; Juan A Gonzalez-Sanchez; W Scott Burgin; Ralph L Sacco; Tatjana Rundek Journal: Stroke Date: 2016-08-23 Impact factor: 7.914
Authors: H Christian Schumacher; Brian T Bateman; Bernadette Boden-Albala; Mitchell F Berman; J P Mohr; Ralph L Sacco; John Pile-Spellman Journal: Ann Emerg Med Date: 2007-05-03 Impact factor: 5.721
Authors: Hugo J Aparicio; Brendan G Carr; Scott E Kasner; Michael J Kallan; Karen C Albright; Dawn O Kleindorfer; Michael T Mullen Journal: J Am Heart Assoc Date: 2015-10-14 Impact factor: 5.501
Authors: J Margo Brooks Carthon; Heather Brom; Matthew McHugh; Marguerite Daus; Rachel French; Douglas M Sloane; Robert Berg; Raina Merchant; Linda H Aiken Journal: Nurs Res Date: 2022 Jan-Feb 01 Impact factor: 2.381
Authors: Suhang Song; Gaoting Ma; Michael G Trisolini; Kenneth A Labresh; Sidney C Smith; Yinzi Jin; Zhi-Jie Zheng Journal: JAMA Netw Open Date: 2021-05-03
Authors: Allison Willis; Lesli E Skolarus; Roland Faigle; Uma Menon; Hannah Redwine; Amanda M Brown; Elizabeth Felton; Adys Mendizabal; Avindra Nath; Frances Jensen; Justin C McArthur Journal: Ann Neurol Date: 2021-08-05 Impact factor: 11.274
Authors: Catherine Cooper Hay; James E Graham; Monique R Pappadis; Angelle M Sander; Ickpyo Hong; Timothy A Reistetter Journal: Am J Phys Med Rehabil Date: 2020-01 Impact factor: 3.412